- Home
- LOGC vs FENC Comparison
LOGC vs FENC Comparison
Compare LOGC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOGC
- FENC
- Stock Information
- Founded
- LOGC 2010
- FENC 1996
- Country
- LOGC United States
- FENC United States
- Employees
- LOGC N/A
- FENC N/A
- Industry
- LOGC Catalog/Specialty Distribution
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LOGC Consumer Discretionary
- FENC Health Care
- Exchange
- LOGC Nasdaq
- FENC Nasdaq
- Market Cap
- LOGC 175.8M
- FENC 156.9M
- IPO Year
- LOGC 2020
- FENC 2001
- Fundamental
- Price
- LOGC $7.91
- FENC $6.65
- Analyst Decision
- LOGC
- FENC Strong Buy
- Analyst Count
- LOGC 0
- FENC 2
- Target Price
- LOGC N/A
- FENC $14.00
- AVG Volume (30 Days)
- LOGC 172.4K
- FENC 58.2K
- Earning Date
- LOGC 03-03-2025
- FENC 03-20-2025
- Dividend Yield
- LOGC N/A
- FENC N/A
- EPS Growth
- LOGC N/A
- FENC N/A
- EPS
- LOGC N/A
- FENC N/A
- Revenue
- LOGC $96,000,000.00
- FENC $49,348,000.00
- Revenue This Year
- LOGC N/A
- FENC $170.43
- Revenue Next Year
- LOGC $422.91
- FENC $6.70
- P/E Ratio
- LOGC N/A
- FENC N/A
- Revenue Growth
- LOGC N/A
- FENC 278.09
- 52 Week Low
- LOGC $4.20
- FENC $3.96
- 52 Week High
- LOGC $8.24
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- LOGC 68.64
- FENC 66.40
- Support Level
- LOGC $7.36
- FENC $6.30
- Resistance Level
- LOGC $6.97
- FENC $6.64
- Average True Range (ATR)
- LOGC 0.29
- FENC 0.29
- MACD
- LOGC 0.11
- FENC 0.06
- Stochastic Oscillator
- LOGC 100.00
- FENC 90.23
About LOGC ContextLogic Inc.
ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives a majority of its revenue from Europe and also has a presence in North America; South America, and other countries.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.